Discovery could help treatments for sickle cell disease
August 16, 2016
DMSE's Ming Dao, along with Postdoc Peter T.C. So, co-authored a study regarding sickle cell disease and the hydroxyurea action.
"Our findings shine a light on the mechanism behind hydroxyurea action, which has long been debated in the scientific community," said Ming Dao, principal research scientist in MIT's Department of Materials Science and Engineering and co-author of the study. "It's exciting to see that using the latest optical imaging tools, we can now confirm which one is the dominating mechanism. Understanding the key mechanism of action will allow us to explore novel and improved therapeutic approaches for sickle cell disease."